Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

Clinical trial NCT05969275 · RECRUITING

Trial details

NCT number: NCT05969275
Sponsor: Ottawa Hospital Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Septic Shock Sepsis Pathologic Processes Shock Systemic Inflammatory Response Syndrome Inflammation Infections

Start date: 2024-02-14
Primary completion: 2026-09-30
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.